Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).

Cancer genetics - 1 Aug 2022

Marinović Sonja, Cigrovski Berković Maja, Zjačić-Rotkvić Vanja, Kapitanović Sanja

Abstract excerpt

OBJECTIVES: Pancreatic neuroendocrine tumors (NETs) are rare and account for about 7% of all cancers occurring in the pancreas. The epidermal growth factor family of receptors and their ligands play an important role in the growth and progression of tumors but their role in PNET development remains unknown. We hypothesized that functional single nucleotide polymorphisms (SNPs) in the EGF, EGFR, and HER2 genes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epidermal Growth Factor
Share to ErbB Receptors
Share to Genes, erbB-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 35777127
DOI: 10.1016/j.cancergen.2022.06.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).PMID 35777127Read ↗

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.Semantic proximity Read ↗

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.Semantic proximity Read ↗

Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.Semantic proximity Read ↗

The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.Semantic proximity Read ↗

Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors.Semantic proximity Read ↗

Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma.Semantic proximity Read ↗

Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls.Semantic proximity Read ↗

Association of single nucleotide polymorphisms of β2-adrenergic receptor gene with clinicopathological features of pancreatic carcinoma.Semantic proximity Read ↗

Are head and neck versus abdominal paragangliomas driven by different single nucleotide events?Semantic proximity Read ↗

Clinical and Genetic Factors Associated with Neuroendocrine Neoplasms: A UK Biobank Study.Semantic proximity Read ↗

Clinical relevance of epidermal growth factor receptor (EGFR) alterations in human pancreatic tumors.Semantic proximity Read ↗

Association between EGF promoter polymorphisms and cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.